Leaflet: Information for the user
Fludetén 500 mg/30 mg effervescent tablets
Paracetamol/Codeine phosphate hemihydrate
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
Fludetén is an association of paracetamol and codeine. Paracetamol is an active analgesic and antipyretic principle (relieves pain and reduces fever) whose analgesic activity is potentiated by codeine. Codeine belongs to a group of medications called opioid analgesics that act by relieving pain.
This medication can be used in adolescents over 15 years of age for the short-term treatment of moderate pain that is not relieved by other analgesics such as paracetamol or ibuprofen alone.
Do not take Fludetén
Warnings and precautions
Consult your doctor or pharmacist before starting to take Fludetén:
Interference with analytical tests
If you are to undergo any analytical test (including blood, urine, skin tests using allergens, etc.) inform your doctor that you are taking Fludetén, as it may alter the results of these tests.
Fludetén with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
In particular, if you are taking medications that contain any of the following active principles, it may be necessary to modify the dose or interrupt treatment with any of them.
Paracetamol may interact with the following medications:
On the other hand, codeine may interact with the following medications:
Do not use other analgesics (pain-relieving medications) without consulting your doctor.
Fludetén with food, drinks, and alcohol
The use of paracetamol in patients who regularly consume alcohol (three or more alcoholic beverages per day) may damage the liver. Additionally, alcohol may potentiate the depressive effect of codeine. Therefore, do not consume alcohol during treatment with this medication.
Children and adolescents
Use in children and adolescents after surgery
Codeine should not be used to relieve pain in children and adolescents after tonsillectomy or adenoidectomy due to obstructive sleep apnea syndrome.
Use in children with respiratory problems
The use of codeine in children with respiratory problems is not recommended, as the symptoms of morphine toxicity may be worse in these children.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before taking this medication.
Do not take this medication if you are breastfeeding. Codeine and morphine pass into breast milk.
Driving and operating machinery
Fludetén contains codeine, which may cause drowsiness, affecting mental and/or physical ability. If you note these effects, avoid driving vehicles or operating machinery.
Fludetén contains sodium
This medication contains 491.4 mg of sodium (main component of table salt/for cooking) in each tablet. This is equivalent to 25% of the recommended daily maximum sodium intake for an adult.
Consult your doctor or pharmacist if you need 1 or more tablets per day for a prolonged period, especially if you have been recommended a low-sodium diet.
Use in athletes:This medication contains codeine. As a result of its metabolism, some compounds are produced that may produce a positive result in doping control tests.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
This medication should not be taken for more than 3 days. If the pain does not improve after 3 days, ask your doctor for advice.
Dosage:
The administration of Fludetén is subject to the appearance of pain, and the dose can be reduced as it disappears. It is essential to use the smallest dose that relieves pain and should not take the medication for longer than necessary.
Adults and adolescents over 15 years:
Follow the doctor's instructions. The recommended dose for adults and adolescents over 15 years is 1 to 2 effervescent tablets, 1 to 4 times every 24 hours. Doses should be spaced at least 4 hours apart.
Do not exceed 6 tablets per day.
Use in children and adolescents
This medication is not recommended for use in adolescents under 15 years old.
Children under 12 years old should not take Fludetén due to the risk of severe respiratory problems.
Patients with kidney and/or liver diseases
If you have a kidney and/or liver disease, your doctor may prescribe a lower dose than usual. If so, take the exact dose prescribed by your doctor.
Older patients
Older patients are more prone to adverse effects, so it may be necessary to reduce the dose. Consult your doctor.
Administration form:
This medication is administered orally.
Dissolve 1 (or 2) tablets in a glass of water and ingest the contents after the effervescence stops.
If you take more Fludetén than you should
If you have taken more Fludetén than you should, consult your doctor or pharmacist immediately, or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
The symptoms of overdose due to paracetamol may be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), and abdominal pain.
In cases where the patient is being treated with barbiturates or has chronic alcoholism, they may be more susceptible to a paracetamol overdose.
The symptoms that characterize a codeine overdose are: drowsiness, even to the point of stupor or coma, cold skin, miosis, muscle flaccidity, and, in some cases, bradycardia, hypotension, and respiratory depression.
If you forget to take Fludetén
Do not take a double dose to compensate for the missed doses.
If you have forgotten a dose, take another as soon as possible and continue with the new schedule, maintaining a minimum interval of 6 hours. However, if the next dose is due soon, skip the missed dose and take the next dose at the usual time.
If you interrupt the treatment with Fludetén
Your doctor will indicate the duration of treatment with Fludetén and when and how to interrupt it.
Do not suspend treatment prematurely, as you will not achieve the expected effect.
There is a risk of possible effects due to withdrawal when suspending treatment. Therefore, in prolonged treatments, doses should be gradually reduced (See section 2).
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
The side effects observed are described below according to the frequency of presentation:
Rare (may affect up to 1 in 1,000 patients) and very rare (may affect up to 1 in 10,000 patients)and unknown (cannot be estimated from available data).
The side effects ofparacetamolare:
Very rarely, severe skin reactions have been reported.
The side effects ofcodeineare:
Reporting of side effects:
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
No special storage conditions are required. Keep the container tightly closed.
Do not use this medication after the expiration date that appears on the container after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of containers and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Fludetén
Appearance of the product and contents of the packaging
Each package contains 20 effervescent tablets, cylindrical, flat, smooth on both sides, and white in color in aluminum tubes coated on the inside with epoxy resin and with a polyethylene cap provided with a desiccant and indicator.
Holder of the marketing authorization and responsible for manufacturing
Laboratorios Alter, S.A.
C/ Mateo Inurria, 30
28036 Madrid
Spain
Last review date of this leaflet: February 2025
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.